To Improve Global Health Security, We Must Not Abandon Tackling Existing Epidemics
Over 600 million people in Africa require treatment for an NTD, making up 35% of the global burden. Credit: Uniting to Combat NTDsBy Thoko Elphick-PooleyHOVE, United Kingdom, Jun 11 2021 (IPS) As world leaders come together in the UK for the G7, the global response to COVID-19 and how we can build a better defence system against infection is at the forefront of discussions.  Whilst we applaud the incredible global efforts in tackling COVID-19 and support calls for vaccines to be shared equitably across the world, we also urge G7 leaders not to abandon efforts to tackle existing epidemics such as neglected tropical dis...
Source: IPS Inter Press Service - Health - June 11, 2021 Category: International Medicine & Public Health Authors: Thoko Elphick Pooley Tags: Headlines Health TerraViva United Nations Neglected Tropical Diseases (NTDs) Source Type: news

St. Louis Character: How Saint Louis University's Dr. Daniel Hoft became one of the nation's leading vaccine experts
On a Peace Corps trip to Malaysia, Dr. Daniel Hoft's malaria research launched him into a 40-year career studying infectious diseases and vaccinology. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 10, 2021 Category: Pharmaceuticals Authors: Maddy Simpson Source Type: news

The 10 Most Important Health Breakthroughs You Missed During the Pandemic
While most eyes were on COVID-19, researchers have also made groundbreaking advancements in other fields. Here’s a look. The other big vaccine news Public-health officials have long sought a vaccine against malaria, which infects up to 600 million people a year and kills 400,000, mostly children. This year, there was dramatic prog­ress toward that goal. In a study of 450 children in Burkina Faso, published in the Lancet in April, researchers reported that a new malaria vaccine, called R21, is 77% effective—just clearing the World Health Organization’s 75% efficacy standard. However, the sample gro...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 feature Innovation Magazine Source Type: news

Preventing the Next Health Crisis Depends on Health Workers. We Need 18 Million More
Over 115,000 health and care workers died during the COVID-19 pandemic. As a physician who’s cared for patients with COVID-19, malaria and Ebola, I’ve seen too many colleagues make the ultimate sacrifice on the frontlines. I’m not surprised experts responding to TIME’s survey ranked bolstering the world’s public health workforce, particularly in rural and remote regions, as one of the top five of nearly 50 strategies to prepare for the next pandemic. But I’m concerned they ranked this the least feasible strategy amongst the top five. Experts ranked high the need for new systems to raise ...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Raj Panjabi Tags: Uncategorized COVID-19 health Magazine Source Type: news

Optimizing immunization with Sanaria ® PfSPZ-CVac malaria vaccine
(Sanaria Inc.) Sanaria and its collaborators have had to take a step by step empirical approach to optimizing immunization with PfSPZ vaccines to achieve a safe, effective, durable, and broadly protective malaria vaccine. Two recent landmark malaria vaccine studies have moved the optimization process forward and highlighted the strong protective efficacy of Sanaria ® PfSPZ-CVac in malaria-na ï ve adults. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2021 Category: International Medicine & Public Health Source Type: news

What Are Some Indications for Using Dexamethasone?
Discussion Corticosteroids are a group of drugs which can be naturally or synthetically produced. Naturally occurring substances are produced in the adrenal gland, and are protein-bound (primarily corticosteroid-binding globulin and albumin). In the target tissues, they may need to be converted to an active substance. They are then reduced, oxidized, hydroxylated or conjugated as measures to inactivate them. Synthetic steroids have less protein binding and depending on their structure are more or less resistant to inactivation. Prednisone is the glucocorticoid most often used for treatment, especially as it has a short hal...
Source: PediatricEducation.org - June 7, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

How COVID-19 Is Revolutionizing Health Care Around the World
In 2020 alone, there were at least 3 million deaths from COVID-19, though the true figure is probably 2-3 times higher. In 2021, the COVID-19 pandemic continues to rage on and is likely to last well into 2022 and beyond. For ten weeks in a row, from the first week of February, 2021, new daily cases globally rose, driven in part by virus variants and by many countries ending public health measures too soon. There are still around 600,000 new cases every day. Nations like Brazil, Canada, India, Iran, and Turkey—as well as some U.S. states like Michigan and Minnesota—recently experienced COVID-19 surges that in so...
Source: TIME: Health - June 3, 2021 Category: Consumer Health News Authors: Gavin Yamey and Madhukar Pai Tags: Uncategorized COVID-19 Source Type: news

Atlas of malaria parasite gene activity provides new targets for drugs and vaccines
(Imperial College London) Researchers have mapped in fine detail the genetic changes malaria parasites go through as they prepare to infect people. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 27, 2021 Category: International Medicine & Public Health Source Type: news

Africa: Hope For A Malaria-Free Africa
[allAfrica] In recent decades, the world has made remarkable progress in the fight against malaria. Over 20 years of investment, commitment, and action have saved over 7.6 million lives and prevented over 1.5 billion malaria cases. We've discovered new ways of protecting ourselves from the deadly mosquito bite -- with insecticide-treated mosquito nets, effective antimalarial treatments, and--most recently--promising new innovations such as gene drive and malaria vaccines bringing us one step close (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - May 25, 2021 Category: Infectious Diseases Source Type: news

Africa: Good News Emerges About a Malaria Vaccine
[CFR] In Africa and elsewhere, COVID-19 dominates media attention. Yet malaria has probably killed four times as many as COVID-19 over the last year in Africa. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 19, 2021 Category: African Health Source Type: news

Uganda: Breakthrough As New Malaria Vaccine Attains 77pc Efficacy
[Monitor] The Tanzanian government said May 14 that it was closely monitoring the recently developed malaria vaccine that has proved to be 'highly effective' in clinical trials. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 17, 2021 Category: African Health Source Type: news

T ü bingen study raises hope for effective malaria vaccine
(German Center for Infection Research) At the University Hospital of Tuebingen, a clinical trial led by Prof. Dr. Peter Kremsner, Director of the Institute of Tropical Medicine and Dr. Rolf Fendel, Research Group Leaderat the Institute of Tropical Medicine partnered with the German Center for Infection Research (DZIF), was able to show that the vaccine, " Sanaria ® PfSPZ-CVac " , which is being developed in Tuebingen together with the biotechnology company Sanaria Inc., provides 77 percent cross-strain protection against malaria parasites. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 5, 2021 Category: Infectious Diseases Source Type: news

Promising malaria vaccine enters final stage of clinical testing in West Africa
(University of Oxford) R21/Matrix-M, a malaria vaccine developed at the Jenner Institute, University of Oxford, showed efficacy of 77% over 12 months in a recently reported phase IIb trial. First vaccinations have now begun in Mali in a larger phase III trial which is hoped to lead to licensure of this malaria vaccine by 2023. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 5, 2021 Category: Infectious Diseases Source Type: news

Kenya: Kenya Administers 450,000 Doses of Malaria Vaccine in Pilot Programme
[East African] Since the malaria vaccine launch in Africa in September 2019, Kenya has managed to administer the total four doses to 4,017 children, says the Ministry of Health. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 30, 2021 Category: Infectious Diseases Source Type: news

Is There Any Vaccine for Malaria
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 28, 2021 Category: General Medicine Source Type: news

Ghana: Over 2,000 Children Vaccinated Against Malaria in AEE District
[Ghanaian Times] Ajumako -- A total of 21,951 children under five years have since 2019 been vaccinated against malaria in the Ajumako-Enyan-Essiam (AEE) District of the Central Region. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 27, 2021 Category: Infectious Diseases Source Type: news

New Malaria Vaccine Shows Most Efficacy of Any to Date: Small Trial
Immunization had up to 77 percent efficacy in a Phase 2 clinical study of 450 children in Burkina Faso. (Source: The Scientist)
Source: The Scientist - April 26, 2021 Category: Science Tags: News & Opinion Source Type: news

Rwanda: Rwanda Optimistic About Latest Breakthrough in Search for a Malaria Vaccine
[New Times] Officials at Rwanda Biomedical Centre (RBC) have said they are optimistic about the recent unprecedented developments in the search for a malaria vaccine, and hope soon there will be a vaccine to complement the existing measures to fight the disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 26, 2021 Category: Infectious Diseases Source Type: news

Africa: 'Landmark' Step in Malaria Vaccines As First Trial Meets WHO Target
[RFI] As the world marks World Malaria Day, a new vaccine has proven 77 percent effective in trials on infants, according to British researchers, in what could prove to be a potential game-changer against the deadly mosquito-borne disease. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 26, 2021 Category: Infectious Diseases Source Type: news

Nigeria: Malaria Vaccine in Nigeria Ready in 6 Months, Ned Nwoko Foundation Says
[Vanguard] The Prince Ned Nwoko Foundation has said that a vaccine for malaria in Nigeria would be available in the next six months. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 26, 2021 Category: Infectious Diseases Source Type: news

Nigeria: Malaria Vaccine Ready in 6 Months, Ned Nwoko Foundation Says
[Vanguard] The Prince Ned Nwoko Foundation has said that a vaccine for malaria in Nigeria would be available in the next six months. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 26, 2021 Category: African Health Source Type: news

New vaccine success for Oxford is truly remarkable | Kenan Malik
Malaria has still not been eradicated in the poorest countries, but that could be about to changeAnother vaccine from Oxford ’s Jenner Institute and one that may have a greater impact than that against Covid-19. Results from trials of itsmalaria vaccine, R21, show it to be 77% effective. If replicated in larger scale trials, it would be a remarkable breakthrough. Malaria kills more than400,000 people a year, almost all in sub-Saharan Africa, and mainly children. Until now, the only approved anti-malarial vaccine, Mosquirix, has had a low level of efficacy – among young children it reduced cases by 39%; in infan...
Source: Guardian Unlimited Science - April 25, 2021 Category: Science Authors: Kenan Malik Tags: Malaria Society Infectious diseases Medical research Source Type: news

Nigeria: Good News for Nigeria, Others As Potential Malaria Vaccine Surpasses 75 Percent Efficacy
[Premium Times] Malaria is a major public health problem in 97 countries - particularly, in Sub-Saharan Africa (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 24, 2021 Category: Infectious Diseases Source Type: news

Kenya: Kenya to Pilot Another Malaria Vaccine Trial
[Nation] Kenya is among four African countries that will carry out a larger trial in nearly 5,000 children, on a malaria vaccine proven to be 77 per cent effective. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 24, 2021 Category: Infectious Diseases Source Type: news

New malaria vaccine offers 77% protection against deadly parasite, researchers say
A new malaria vaccine developed by researchers at the University of Oxford provides 77% protection against the mosquito-borne parasite for one year, a study published online Friday by the Lancet found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 23, 2021 Category: Consumer Health News Source Type: news

A new malaria vaccine has proven 77 percent effective in trials on infants, British researchers said Friday, in what could prove to be a...
'Landmark' advance as malaria vaccine first to hit WHO goal (Source: Reuters: Health)
Source: Reuters: Health - April 23, 2021 Category: Consumer Health News Source Type: news

Africa: Malaria Vaccine Becomes First to Achieve WHO-specified 75% Efficacy Goal
[Oxford University] Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 23, 2021 Category: Infectious Diseases Source Type: news

Africa: RTS,S Malaria Vaccine Reaches More Than 650 000 Children in Ghana, Kenya and Malawi Through Groundbreaking Pilot Programme
[WHO] Malaria vaccine coverage through childhood immunization programme signals strong community demand for vaccine. (Source: AllAfrica News: Malaria)
Source: AllAfrica News: Malaria - April 23, 2021 Category: Infectious Diseases Source Type: news

Malaria vaccine hailed as potential breakthrough
Early trials show Oxford developers may have finally found an effective jab against the disease. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 23, 2021 Category: Consumer Health News Source Type: news

Malaria vaccine trial raises hopes of beating disease
Jab developed by University of Oxford team proves 77% effective in Burkina Faso mid-stage tests (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 23, 2021 Category: Pharmaceuticals Source Type: news

Oxford Malaria vaccine proves highly effective in Burkina Faso trial
Vaccine developed by scientists at Jenner Institute, Oxford, shows up to 77% efficacy in trial over 12 monthsA vaccine against malaria has been shown to be highly effective in trials in Africa, holding out the real possibility of slashing the death toll of a disease that kills 400,000 mostly small children every year.The vaccine, developed by scientists at the Jenner Institute of Oxford University, showed up to 77% efficacy in a trial of 450 children in Burkina Faso over 12 months.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 23, 2021 Category: Science Authors: Sarah Boseley Health editor Tags: Malaria World news Vaccines and immunisation Health Society Africa Science UK news University of Oxford Source Type: news

Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal
(University of Oxford) * High-level vaccine efficacy of 77% in African children achieve WHO-specified efficacy goal of 75%* Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated* Vaccine candidate, R21/Matrix-M, has excellent potential for large-scale manufacturing and low-cost supply (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 23, 2021 Category: International Medicine & Public Health Source Type: news

'Landmark' advance as malaria vaccine first to hit WHO goal
In a clinical trial in Burkina Faso, the Matrix-M vaccine -- developed by the University of Oxford's Jenner Institute -- was found to be 77 percent effective after 450 infants inoculated in 2019 were followed up for a year, the Oxford researchers said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 23, 2021 Category: Pharmaceuticals Source Type: news

Women and Girls to the Front
This article was originally published in Forbes Africa.   Follow @IPSNewsUNBureau !function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?'http':'https';if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+'://platform.twitter.com/widgets.js';fjs.parentNode.insertBefore(js,fjs);}}(document, 'script', 'twitter-wjs');   The post Women and Girls to the Front appeared first on Inter Press Service. Excerpt: Gender Equality in STEM for a better tomorrow The post Women and Girls to the Front appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - April 6, 2021 Category: International Medicine & Public Health Authors: Siddharth Chatterjee and Ali Obaid Al Dhaheri Tags: Asia-Pacific Development & Aid Economy & Trade Education Gender Headlines Health Humanitarian Emergencies Inequity Poverty & SDGs TerraViva United Nations Women & Economy Source Type: news

'Mop up' malaria vaccine advances to trials in people
(University of Florida) University of Florida researcher Rhoel Dinglasan, Ph.D., was awarded $6 million today by the Global Health Innovative Technology Fund to test a new malaria vaccine in people. The process leading to a phase 1 clinical trial begins this April. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 30, 2021 Category: Infectious Diseases Source Type: news

WRAIR, Duke scientists find evidence of monoclonal antibodies activity against malaria
(Walter Reed Army Institute of Research) Scientists at Walter Reed Army Institute of Research, in a collaboration the Duke University, have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria, identifying two potential mAbs for further development. Decades of malaria vaccine research have shown low efficacy in field trials conducted in several countries in Africa. Many researchers around the world have now focused their attention on using mAbs against the circumsporozoite protein of the parasite. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 5, 2021 Category: Infectious Diseases Source Type: news

First vaccine to fully immunize against malaria builds on pandemic-driven RNA tech
(Source: Reuters: Health)
Source: Reuters: Health - February 27, 2021 Category: Consumer Health News Source Type: news

Open data on malaria genomes will help combat drug resistance
(Wellcome Trust Sanger Institute) Genome variation data on more than 7,000 malaria parasites from 28 endemic countries is released today. It has been produced by MalariaGEN, a data-sharing network of groups around the world who are working together to build high-quality data resources for malaria research and disease control. This open data release provides benchmark data on parasite genome variation that is needed in the search for new drugs and vaccines, and in the development of surveillance tools for malaria control and elimination. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 24, 2021 Category: Infectious Diseases Source Type: news

It ’s Not Clear That We Actually Need Human Challenge Trials for COVID-19, But the U.K. Is Moving Ahead With Them Anyway
On Feb. 17, health officials in the UK announced that they are ready to start exposing healthy volunteers to the COVID-19 virus in a carefully controlled study. The so-called human challenge trial is the first of its kind for COVID-19 and will help scientists learn how much virus is needed to cause infection, among other important questions. The practice of intentionally exposing healthy people to a disease-causing (and potentially deadly) pathogen isn’t new in science, but it remains controversial. Scientists must balance the benefits of exposing people—which mostly fall in the realm of new knowledge about the...
Source: TIME: Health - February 18, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Job vacancies with Cochrane Infectious Diseases - Liverpool, UK
The   Centre for Evidence Synthesis in Global Health has led developments in systematic reviews in tropical medicine and international health. In the 1990s, staff contributed to setting up Cochrane, and established theCochrane Infectious Diseases Group (CIDG). This is now recognised as one of Cochrane ’s premier groups, with over 150 Cochrane reviews and 600 authors, and is well-linked with the World Health Organization. Two job positions are currently being advertised with the Centre.Take a look at  www.evidence4health.org/  and  https://cidg.cochrane.org/ where you will find annua...
Source: Cochrane News and Events - February 10, 2021 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Could a vaccine get rid of malaria for good?
Seventeen-year-old Victoline explores progress to tackle the disease in her home country, Kenya. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 31, 2021 Category: Consumer Health News Source Type: news

GSK transfers malaria vaccine production to India's Bharat Biotech
The agreement includes transfer of manufacturing of the protein part of the vaccine, RTS,S/AS01, while GSK will continue to supply Bharat Biotech with the adjuvant or vaccine booster for the shot, the London-listed company said. (Source: The Economic Times)
Source: The Economic Times - January 27, 2021 Category: Consumer Health News Source Type: news

Top Global Health Moments of 2020
By The Editorial Team, IntraHealth International Community Health Nurse Olivia Yeboah thoroughly washes her hands at the Akropong Clinic in Ghana. Photo by Emmanuel Attramah, PMI Impact Malaria/US President's Malaria Initiative.December 17, 2020If we wanted to, we could list a COVID-19 moment for every month of 2020.  We all know that the onset of the coronavirus pandemic—first in China and then worldwide—overwhelmed news coverage this year. And with good reason. It’s the first large-scale global pandemic in 100 years. At the time this article was publ...
Source: IntraHealth International - December 17, 2020 Category: International Medicine & Public Health Authors: kseaton Tags: HIV & AIDS COVID-19 Nutrition Policy Advocacy Health Workforce Systems Nursing Midwifery 2020 Health Workers Source Type: news

Africa Should Be at the Forefront of a Global Response to COVID-19
Women in Nigeria collect food vouchers as part of a programme to support families struggling under the COVID-19 lockdown. Credit: WFP/Damilola OnafuwaBy Aeneas Chapinga ChumaJOHANNESBURG, Nov 27 2020 (IPS) As COVID-19 swept across the globe, one thing became clear: a well-functioning, well-resourced, agile and resilient health system can mean the difference between life and death. For Africa, the economic costs of the health pandemic were high. The prescription was often worse than the illness as Africa’s poor found themselves without work, food and even access to health care as economies were locked down across the ...
Source: IPS Inter Press Service - Health - November 27, 2020 Category: International Medicine & Public Health Authors: Aeneas Chapinga Chuma Tags: Africa Headlines Health Poverty & SDGs Source Type: news

The volunteers lining up for Covid-19 challenge trials
Non-profit organisation 1Day Sooner has attracted over 38,500 willing participantsCovid: firm secures £10m to infect young volunteers to hasten vaccineHuman challenge trials – in which young, healthy volunteers are intentionally infected with a virus to allow vaccines and treatments to be tested quickly – have been used in the fight against diseases ranging from typhoid and cholera to malaria.Withthe announcement on Tuesday of such trials to help develop a vaccine against Covid-19 there is a key difference – there are as yet very few proven therapies for the virus and we know little about its long-t...
Source: Guardian Unlimited Science - October 20, 2020 Category: Science Authors: Natalie Grover Science correspondent Tags: Coronavirus UK news Infectious diseases Science Medical research Source Type: news

COVID-19: Examining Theories for Africa ’ s Low Death Rates
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post COVID-19: Examining Theories for Africa’s Low Death Rates appeared first on Inter Press Service. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - October 11, 2020 Category: International Medicine & Public Health Authors: External Source Tags: Africa Headlines Health Source Type: news

Injectable hydrogel could someday lead to more effective vaccines
(American Chemical Society) Vaccines have curtailed the spread of several infectious diseases, such as smallpox, polio and measles. However, vaccines against some diseases, including HIV-1, influenza and malaria, don't work very well, and one reason could be the timing of antigen and adjuvant presentation to the immune system. Now, researchers reporting inACS Central Science developed an injectable hydrogel that allows sustained release of vaccine components, increasing the potency, quality and duration of immune responses in mice. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 16, 2020 Category: Infectious Diseases Source Type: news

The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

Transforming the Global Economy or Parachuting Cats into Borneo?
Credit: United Nations Office for Disaster Risk Reduction (UNDRR)By Lawrence SurendraBANGKOK, Thailand, Aug 24 2020 (IPS) The COVID 19 Pandemic continues relentlessly. Deaths approaching a million globally, 22 million infected and growing. Brazil, India, the US and Russia accounting for almost 50% of the total cases in the world. Medically the promise of a vaccine is given as signs of hope; what surprises awaits us when such a vaccine is available, would be another story. Economically, to address the uncertainty and the grim future ahead, the UN, some governments and even Joe Biden the US Presidential hopeful, are waving ...
Source: IPS Inter Press Service - Health - August 24, 2020 Category: International Medicine & Public Health Authors: Lawrence Surendra Tags: Development & Aid Featured Global Headlines Health Humanitarian Emergencies IPS UN: Inside the Glasshouse Population Poverty & SDGs TerraViva United Nations Source Type: news

FDA Authorizes Use of Plasma From Recovered Patients to Treat COVID-19
(WASHINGTON) — President Donald Trump on Sunday announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called “a breakthrough,” one of his top health officials called “promising” and other health experts said needs more study before it’s celebrated. The announcement came after White House officials complained there were politically motivated delays by the Food and Drug Administration in approving a vaccine and therapeutics for the disease that has upended Trump’s reelection chances. On the eve of the Republican National Convention, T...
Source: TIME: Health - August 24, 2020 Category: Consumer Health News Authors: Jonathan Lemire an Mike Stobbe / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news